Clinical Trial Update: A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A pilot Phase 2/3 trial evaluating BMS-512148 in people with type 2 diabetes has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BMS-512148

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-05-11